Related Experiment Videos
Genotype-phenotype correspondence in Sanfilippo syndrome type B
H G Zhao1, E L Aronovich, C B Whitley
1Gene Therapy Program, Institute of Human Genetics, Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA.
American Journal of Human Genetics
|March 7, 1998
Summary
Researchers identified new mutations in the alpha-N-acetylglucosaminidase (NAGLU) gene, doubling known mutations for Sanfilippo syndrome type B. This advances understanding of the genetic basis for this rare disease.
Area of Science:
- Genetics
- Biochemistry
- Rare Diseases
Background:
- Sanfilippo syndrome type B (mucopolysaccharidosis type IIIB) is caused by defects in the alpha-N-acetylglucosaminidase (NAGLU) gene.
- The number of described mutations in the NAGLU gene has been limited, hindering comprehensive genetic analysis.
Purpose of the Study:
- To develop and apply a rapid, automated sequencing method for identifying mutations in the entire coding region of the NAGLU gene.
- To significantly expand the catalog of known NAGLU mutations associated with Sanfilippo syndrome type B.
Main Methods:
- An automated sequencing procedure was employed to analyze the complete coding region and exon-intron boundaries of the NAGLU gene.
- Eight families affected by Sanfilippo syndrome type B were studied, with all 16 alleles analyzed.
Main Results:
- The study identified mutations in all 16 alleles from the eight families, more than doubling the previously published NAGLU mutations.
- Eight novel mutations were described, including five missense, two nonsense, and one insertion mutation.
- A specific mutation at codon R674 was found to be prevalent (36% of point mutations), potentially indicating a common or ancient mutation.
Conclusions:
- The developed automated sequencing method is effective for rapid and comprehensive identification of NAGLU mutations.
- The findings expand the known mutational landscape of Sanfilippo syndrome type B, providing crucial data for genotype-phenotype correlations.
- Understanding these mutations is vital for evaluating future therapeutic strategies, such as gene therapy.